LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Decision (EU) 2022/207 of 15 February 2022 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the Hashemite Kingdom of Jordan to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)

Commission Implementing Decision (EU) 2022/207 of 15 February 2022 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the Hashemite Kingdom of Jordan to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)

Implementing Decision (EU) 2022/207 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

COVID-19 vaccination certificates issued by the Hashemite Kingdom of Jordan in accordance with the ‘COVID-19 Vaccination Certificate’ system shall, for the purpose of facilitating the right of free movement within the Union, be considered as equivalent to those issued in accordance with Regulation (EU) 2021/953.

Article 2

Open ↗

The Hashemite Kingdom of Jordan shall be connected to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953.

Article 3

Open ↗

This Decision shall enter into force on the day of its publication in the Official Journal of the European Union .

Other acts of the same type
Decision (EU) 2021/1437 of the European Central Bank of 3 August 2021 amending Decision (EU) 2017/934 on the delegation of decisions on the significance of supervised entities (ECB/2021/33)Decision (EU) 2021/1438 of the European Central Bank of 3 August 2021 amending Decision (EU) 2017/935 on delegation of the power to adopt fit and proper decisions and the assessment of fit and proper requirements (ECB/2021/34)Decision (EU) 2021/1439 of the European Central Bank of 3 August 2021 amending Decision (EU) 2018/546 on delegation of the power to adopt own funds decisions (ECB/2021/35)Decision (EU) 2021/1440 of the European Central Bank of 3 August 2021 amending Decision (EU) 2019/1376 on delegation of the power to adopt decisions on passporting, acquisition of qualifying holdings and withdrawal of authorisations of credit institutions (ECB/2021/36)Decision (EU) 2021/1441 of the European Central Bank of 3 August 2021 amending Decision (EU) 2019/322 on delegation of the power to adopt decisions regarding supervisory powers granted under national law (ECB/2021/37)Decision (EU) 2021/1442 of the European Central Bank of 3 August 2021 on delegation of the power to adopt decisions on internal models and on extension of deadlines (ECB/2021/38)Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1284 of 2 August 2021 postponing the expiry date of approval of aluminium phosphide for use in biocidal products of product-types 14 and 18 (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1285 of 2 August 2021 postponing the expiry date of approval of magnesium phosphide for use in biocidal products of product-type 18 (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1286 of 2 August 2021 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1287 of 2 August 2021 postponing the expiry date of approval of indoxacarb for use in biocidal products of product-type 18 (Text with EEA relevance)Commission Implementing Decision (EU) 2021/1288 of 2 August 2021 postponing the expiry date of approval of boric acid for use in biocidal products of product-type 8 (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next